Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up

Author:

Yu Ming‐Whei1ORCID,Wu Wan‐Jung1,Lin Chih‐Lin2,Liu Chun‐Jen345ORCID,Peng Wei‐Ya1,Huang Pin‐Yu1,Huang Yi‐Wen6ORCID,Hu Jui‐Ting7,Chang Hung‐Chuen89,Liou Jyh‐Ming31011ORCID

Affiliation:

1. Institute of Epidemiology and Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan

2. Department of Gastroenterology Ren‐Ai Branch Taipei City Hospital Taipei Taiwan

3. Division of Gastroenterology and Hepatology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

4. Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan

5. Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan

6. Graduate Institute of Clinical Medicine College of Medicine Taipei Medical University Taipei Taiwan

7. Liver Center Cathay General Hospital Medical Center School of Medicine Fu‐Jen Catholic University College of Medicine Taipei Taiwan

8. Division of Gastroenterology Department of Internal Medicine Shin Kong Wu Ho‐Su Memorial Hospital Taipei Taiwan

9. School of Medicine Fu Jen Catholic University College of Medicine Taipei Taiwan

10. Department of Internal Medicine National Taiwan University College of Medicine Taipei Taiwan

11. Department of Internal Medicine National Taiwan University Cancer Center Taipei Taiwan

Abstract

AbstractAimTo examine the dynamic change in hepatic steatosis status during repeated assessments over time, and its potential impact on the risk of developing cardiovascular disease (CVD).MethodsWe assessed trajectories of hepatic steatosis and other metabolic disorders in 3134 middle‐aged adults undergoing longitudinal assessment of ultrasonography during a pre‐baseline period (1993–2009) in a population‐based cohort study of liver health. Subsequently, we determined the association of hepatic steatosis trajectories with the incidence of CVD among 2185 CVD‐free individuals, followed until 2021. Metabolic risk factors and cardiovascular events (including coronary heart disease and stroke) were determined through medical examination and linkage with nationwide health databases.ResultsWe identified three discrete trajectories of hepatic steatosis according to changing pattern over time through group‐based trajectory modeling: “stable, non‐steatosis” (n = 1298), “intermittent” (n = 921), and “persistent steatosis” (n = 915). During the pre‐baseline period, hepatic steatosis trajectories were associated with trajectories of developing diabetes and hypertension, and persistent steatosis (vs. other trajectories) was associated with higher risks and rapidly progressive disease patterns. At a median 13.6 years of follow‐up, 629 CVD events occurred. A persistent (vs. non‐steatosis: HR 1.44, 95% CI 1.17–1.76), but not intermittent, steatosis pattern predicted the future risk of CVD, after adjustment for age, sex, smoking, and obesity. This association was independent of genetic background, and remained after accounting for pre‐baseline body‐mass index, other cardiometabolic risk factors, Framingham risk score, medications, and hepatic fibrosis score.ConclusionsThe persistence of hepatic steatosis is associated with trajectories of metabolic disorder development and increased risk of CVD. These data have important implications for practice and further research.

Funder

National Science and Technology Council

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3